Press Release | Association for Accessible Medicines

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Jul 1, 2021 | Rachel Schwartz

AAM Statement on the Anniversary of USMCA

The Maine State House in Augusta, Maine.

Jun 30, 2021 | Rachel Schwartz

AAM Statement on Gov. Mills’ Veto of LD 1117

The Maine State Capitol building in Augusta

Jun 18, 2021 | Rachel Schwartz

AAM Statement on Governor Mill’s Consideration of LD 1117

United States Supreme Court in Washington DC. with Statue of the Guardian or Authority of Law.

Jun 17, 2021 | Rachel Schwartz

AAM and Biosimilars Council Statement on ACA Ruling in California v. Texas

The Maine State Capitol building in Augusta

Jun 16, 2021 | Rachel Schwartz

AAM Statement on Maine LD 1117

The back lawn of the White House with its trees and fountain

Jun 8, 2021 | Rachel Schwartz

AAM Statement on Biden-Harris Administration’s 100-Day Supply Chain Review

Black Women’s Health Imperative (BWHI)

May 26, 2021 | Rachel Schwartz

Black Women’s Health Imperative Named AAM’s 2021 “Champion of Access”

AAM board room

May 24, 2021 | Erica Klinger

AAM Names Erik Komendant Senior Vice President, Government Affairs

Close up shot of vaccines and syringe in a laboratory

May 24, 2021 | Rachel Schwartz

Steven Selde Joins AAM’s Biosimilars Council as Director

May 17, 2021 | Rachel Schwartz

Monét Stanford Joins AAM as Director, Policy

Happy senior male customer buying medications at drugstore

Apr 29, 2021 | Rachel Schwartz

AAM Statement on The Protecting Access to Affordable Medicines Act

Apr 27, 2021 | Rachel Schwartz

AAM Statement on the Ensuring Access to Lower-Cost Medicines for Seniors Act